Literature DB >> 15652453

Microenvironmental control of premalignant disease: the role of intercellular adhesion in the progression of squamous cell carcinoma.

Addy Alt-Holland1, Weitian Zhang, Alexander Margulis, Jonathan A Garlick.   

Abstract

Interactions between potentially neoplastic cells and their normal neighbors act as an important microenvironmental control during the premalignant, intraepithelial (IE) stage of squamous cell cancer development. Using human three-dimensional (3D) tissue models, it has been shown that such interactions induce a state of IE dormancy in which cancer progression is suppressed. This dormant state can be overcome by altering tissue dynamics in response to the tumor promoter TPA, UV irradiation, decreasing adhesive interactions between tumor cells and adjacent epithelia or enabling tumor cells to interact with basement membrane proteins. This chapter will provide an overview of investigations that have characterized how the tissue microenvironment can regulate the incipient development of squamous cell carcinoma.

Entities:  

Mesh:

Year:  2005        PMID: 15652453     DOI: 10.1016/j.semcancer.2004.08.007

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  17 in total

Review 1.  Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions.

Authors:  Jennifer Barrila; Andrea L Radtke; Aurélie Crabbé; Shameema F Sarker; Melissa M Herbst-Kralovetz; C Mark Ott; Cheryl A Nickerson
Journal:  Nat Rev Microbiol       Date:  2010-11       Impact factor: 60.633

2.  Carcinogenesis and metastasis now in the third dimension--what's in it for pathologists?

Authors:  Carlos Sonnenschein; Ana M Soto
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Species-specific fibroblasts required for triggering invasiveness of partially transformed oral keratinocytes.

Authors:  Daniela Elena Costea; Keerthi Kulasekara; Evelyn Neppelberg; Anne Christine Johannessen; Olav Karsten Vintermyr
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

4.  The modulatory effect of cell–cell contact on the tumourigenic potential of pre-malignant epithelial cells: a computational exploration.

Authors:  D C Walker; J Southgate
Journal:  J R Soc Interface       Date:  2012-11-08       Impact factor: 4.118

5.  Influence of individual cell motility on the 2D front roughness dynamics of tumour cell colonies.

Authors:  N E Muzzio; M A Pasquale; P H González; A J Arvia
Journal:  J Biol Phys       Date:  2014-06-04       Impact factor: 1.365

6.  The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma.

Authors:  Teresa M DesRochers; Yulia Shamis; Addy Alt-Holland; Yasusei Kudo; Takashi Takata; Guangwen Wang; Laurie Jackson-Grusby; Jonathan A Garlick
Journal:  Epigenetics       Date:  2012-01-01       Impact factor: 4.528

7.  Cancer cell-derived clusterin modulates the phosphatidylinositol 3'-kinase-Akt pathway through attenuation of insulin-like growth factor 1 during serum deprivation.

Authors:  Hakryul Jo; Yonghui Jia; Kulandayan K Subramanian; Hidenori Hattori; Hongbo R Luo
Journal:  Mol Cell Biol       Date:  2008-05-05       Impact factor: 4.272

Review 8.  [Relevance of cell culture models in cutaneous tumour biology: part II: complex culture systems].

Authors:  J Hatina; T Ruzicka
Journal:  Hautarzt       Date:  2008-02       Impact factor: 0.751

9.  E-cadherin suppression directs cytoskeletal rearrangement and intraepithelial tumor cell migration in 3D human skin equivalents.

Authors:  Addy Alt-Holland; Yulia Shamis; Kathleen N Riley; Teresa M DesRochers; Norbert E Fusenig; Ira M Herman; Jonathan A Garlick
Journal:  J Invest Dermatol       Date:  2008-06-05       Impact factor: 8.551

10.  Differential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathway.

Authors:  J O Humtsoe; R H Kramer
Journal:  Oncogene       Date:  2009-11-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.